image

SEC Filings

We are focused on the rapid design and development of new medicines based on breakthroughs in cancer research.
Filing date Description Form View

Initial filing by director officer or owner of more than ten percent.

3 View HTML

Initial filing by director officer or owner of more than ten percent.

3 View HTML

Initial filing by director officer or owner of more than ten percent.

3 View HTML

EFFECT

EFFECT View HTML

Amended Registration statement for face-amount certificate companies

S-1/A View HTML

Amended Registration statement for face-amount certificate companies

S-1/A View HTML

Registration of certain classes of securities 12(b) of the Securities Exchange Act

8-A12B View HTML

Registration statement for face-amount certificate companies

S-1 View HTML

Form D

D View HTML

Amendment to a previously filed DRS

DRS/A View HTML

Data provided by Kaleidoscope.